NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation

American Journal of Transplantation

Volumn 6, Issue 2, 2006, Pages 292-304

  Kean, L S ^a,b,c   Hamby, K ^a   Koehn, B ^d   Lee, E ^a   Coley, S ^a   Stempora, L ^a   Adams, A B ^a   Heiss, E ^a   Pearson, T C ^a,c   Larsen, C P ^a,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d NONE

Author keywords

LFA 1; Natural killer; Tolerance

Indexed keywords

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL KILLING; CELL SURVIVAL; CELL TRANSFER; CHIMERA; CONTROLLED STUDY; CYTOTOXICITY; DONOR; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TARGET CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644915526     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01172.x     Document Type: Article

References (62)

1. Rothstein DM Sayegh MH T-cell costimulatory pathways in allograft rejection and tolerance Immunol Rev 2003 196 85 108
2. Durham MM Bingaman AW Adams AB et al Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning J Immunol 2000 165 1 4
3. Bingaman AW Waitze SY Alexander DZ et al Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning Transplantation 2000 69 2491 2496
4. Adams AB Durham MM Kean L et al Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression J Immunol 2001 167 1103 1111
5. Abe M Qi J Sykes M Yang YG Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier Blood 2002 99 3823 3829
6. Sykes M Spitzer TR Non-myeloblative induction of mixed hematopoietic chimerism: Application to transplantation tolerance and hematologic malignancies in experimental and clinical studies Cancer Treat Res 2002 110 79 99
7. Wekerle T Sykes M Mixed chimerism as an approach for the induction of transplantation tolerance Transplantation 1999 68 459 467
8. Pearson TC Alexander DZ Hendrix R et al CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism Transplantation 1996 61 997 1004
9. Wekerle T Nikolic B Pearson DA Swenson KG Sykes M Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance Transpl Int 2002 15 248 253
10. Wekerle T Kurtz J Ito H et al Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment Nat Med 2000 6 464 469
11. Mapara MY Pelot M Zhao G Swenson K Pearson D Sykes M Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance Biol Blood Marrow Transplant 2001 7 646 655
12. Kirk AD Transplantation tolerance: A look at the nonhuman primate literature in the light of modern tolerance theories Crit Rev Immunol 1999 19 349 388
13. Kirk AD Crossing the bridge: Large animal models in translational transplantation research Immunol Rev 2003 196 176 196
14. Knechtle SJ Hamawy MM Hu H Fechner JH Jr. Cho CS Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation Immunol Rev 2001 183 205 213
15. Sachs DH Tolerance: Of mice and men [comment] J Clin Invest 2003 111 1819 1821
16. Chargui J Oyama A Yoshimura R Wada S Hase T Kishimoto T Inhibition of NK cell activity induces improvement and stable chimerism after allogeneic transplantation Transplant Proc 2000 32 2462 2463
17. Murphy WJ Kumar V Bennett M Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized J Exp Med 1987 166 1499 1509
18. Yu YY Kumar V Bennett M Murine natural killer cells and marrow graft rejection Annu Rev Immunol 1992 10 189 213
19. Murphy WJ Koh CY Raziuddin A Bennett M Longo DL Immunobiology of natural killer cells and bone marrow transplantation: Merging of basic and preclinical studies Immunol Rev 2001 181 279 289
20. Bennett M Kumar V Mikhael A et al Rejection of bone marrow cells by irradiated mice: NK and T cells recognize different antigens Transplant Proc 1987 19 5 11
21. Tadaki DK Craighead N Saini A et al Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity Transplantation 2000 70 162 167
22. Cudkowicz G Bennett M Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice J Exp Med 1971 134 83 102
23. Kumar V George T Yu YY Liu J Bennett M Role of murine NK cells and their receptors in hybrid resistance Curr Opin Immunol 1997 9 52 56
24. Maier S Tertilt C Chambron N et al Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice Nat Med 2001 7 557 562
25. Oberg L Johansson S Michaelsson J et al Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways Eur J Immunol 2004 34 1646 1653
26. Westerhuis G Maas WG Willemze R Toes RE Fibbe WE Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance Blood 2005 106 2215 2220
27. Ogasawara K Benjamin J Takaki R Phillips JH Lanier LL Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts Nat Immunol 2005 6 938 945
28. Seung E Mordes JP Rossini AA Greiner DL Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning J Clin Invest 2003 112 795 808
29. Yoshino H Ueda T Kawahata M et al Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice Bone Marrow Transplant 2000 26 1211 1216
30. Lee LA Sergio JJ Sykes M Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells Transplantation 1996 61 125 132
31. Manilay JO Waneck GL Sykes M Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras Int Immunol 1998 10 1943 1955
32. George TC Ortaldo JR Lemieux S Kumar V Bennett M Tolerance and alloreactivity of the Ly49D subset of murine NK cells J Immunol 1999 163 1859 1867
33. Sykes M Ohdan H Manilay JO Wekerle T Yang YG Hematopoietic chimerism and tolerance of T cells, B cells, and NK cells Transplant Proc 1998 30 4020
34. Zhao Y Ohdan H Manilay JO Sykes M NK cell tolerance in mixed allogeneic chimeras J Immunol 2003 170 5398 5405
35. Wilk E Korten S Zielinska-Skowronek M Schmidt RE Meyer-Olson D Modulation of Ly49 D expression after allogeneic bone marrow transplantation and functional consequences Immunobiology 2002 205 267 281
36. Johansson MH Bieberich C Jay G Karre K Hoglund P Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene J Exp Med 1997 186 353 364
37. Milicevic NM Nohroudi K Milicevic Z Westermann J Blood lymphocytes, monocytes and NK cells modulate their expression of CD44, ICAM-1, LFA-1 and MHC class II after arrival into lymphoid organs Immunol Invest 2004 33 439 452
38. Milicevic NM Milicevic Z Westermann J Lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 expression on B-cell subsets and the effects of splenectomy-experimental studies Leuk Lymphoma 2002 43 2071 2074
39. Standeven LJ Carlin LM Borszcz P Davis DM Burshtyn DN The actin cytoskeleton controls the efficiency of killer Ig-like receptor accumulation at inhibitory NK cell immune synapses J Immunol 2004 173 5617 5625
40. Barber DF Faure M Long EO LFA-1 contributes an early signal for NK cell cytotoxicity J Immunol 2004 173 3653 3659
41. Klein E Di Renzo L Yefenof E Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells Mol Immunol 1990 27 1343 1347
42. Perez OD Mitchell D Jager GC Nolan GP LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56+CD8+ natural killer cells Blood 2004 104 1083 1093
43. Metzler B Gfeller P Bigaud M et al Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection J Immunol 2004 173 7025 7036
44. Leonardi CL Current concepts and review of efalizumab in the treatment of psoriasis Dermatol Clin 2004 22 427 435 ix
45. Leonardi CL Papp KA Gordon KB et al Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial J Am Acad Dermatol 2005 52 425 433
46. Williams MA Tan JT Adams AB et al Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance J Immunol 2001 167 4987 4995
47. Barber DL Wherry EJ Ahmed R Cutting edge: Rapid in vivo killing by memory CD8 T cells J Immunol 2003 171 27 31
48. Ikuta K Uchida N Friedman J Weissman IL Lymphocyte development from stem cells Annu Rev Immunol 1992 10 759 783
49. Spangrude GJ Smith L Uchida N et al Mouse hematopoietic stem cells Blood 1991 78 1395 1402
50. Ikuta K Ingolia DE Friedman J Heimfeld S Weissman IL Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor Int J Cell Cloning 1991 9 451 460
51. Jackson KA Majka SM Wulf GG Goodell MA Stem cells: A minireview J Cell Biochem Suppl 2002 38 1 6
52. Wognum AW Eaves AC Thomas TE Identification and isolation of hematopoietic stem cells Arch Med Res 2003 34 461 475
53. Corbascio M Mahanty H Osterholm C et al Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice Transplantation 2002 74 35 41
54. Dedrick RL Walicke P Garovoy M Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody Transpl Immunol 2002 9 181 186
55. Brehm MA Daniels KA Ortaldo JR Welsh RM Rapid conversion of effector mechanisms from NK to T Cells during virus-induced lysis of allogeneic implants in vivo J Immunol 2005 174 6663 6671
56. Hoppe CC Walters MC Bone marrow transplantation in sickle cell anemia Curr Opin Oncol 2001 13 85 90
57. Platt OS Guinan EC Bone marrow transplantation in sickle cell anemia - the dilemma of choice N Engl J Med 1996 335 426 428
58. Blazar BR Taylor PA Boyer MW Panoskaltsis-Mortari A Allison JP Vallera DA CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells J Immunol 1997 159 3460 3473
59. Seung E Iwakoshi N Woda BA et al Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice Blood 2000 95 2175 2182
60. Taylor PA Panoskaltsis-Mortari A Noelle RJ Blazar BR Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody J Immunol 2000 164 612 622
61. Taylor PA Friedman TM Korngold R Noelle RJ Blazar BR Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell Blood 2002 99 4601 4609
62. Soper BW Lessard MD Jude CD Schuldt AJ Bunte RM Barker JE Successful allogeneic neonatal bone marrow transplantation devoid of myeloablation requires costimulatory blockade J Immunol 2003 171 3270 3277